160 related articles for article (PubMed ID: 1694150)
1. Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY
Gastroenterol Jpn; 1990 Jun; 25(3):388-93. PubMed ID: 1694150
[TBL] [Abstract][Full Text] [Related]
2. Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY; Ton TC
Cancer Invest; 1991; 9(2):137-43. PubMed ID: 1713804
[TBL] [Abstract][Full Text] [Related]
3. The biological significance of serum complements C3 and C4 in HCV-related chronic liver diseases and hepatocellular carcinoma.
Ali OS; Abo-Shadi MA; Hammad LN
Egypt J Immunol; 2005; 12(2):91-9. PubMed ID: 17977214
[TBL] [Abstract][Full Text] [Related]
4. [A clinical study of complements as a marker of a hepatocellular carcinoma].
Takezaki E; Murakami S; Nishibayashi H; Kagawa K; Ohmori H
Gan No Rinsho; 1990 Oct; 36(12):2119-22. PubMed ID: 1700167
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH
Br J Cancer; 1995 Aug; 72(2):442-6. PubMed ID: 7543774
[TBL] [Abstract][Full Text] [Related]
7. Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Kashala LO; Kalengayi MM; Essex M
Cancer Invest; 1992; 10(6):513-22. PubMed ID: 1384940
[TBL] [Abstract][Full Text] [Related]
8. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
9. Elevated IgG and decreased complement component C3 and factor B in B-thalassaemia major.
Sinniah D; Yadav M
Acta Paediatr Scand; 1981 Jul; 70(4):547-50. PubMed ID: 6914868
[TBL] [Abstract][Full Text] [Related]
10. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
11. [Circulating immune complexes, detection in human glomerulonephritis by the PEG-EDTA technique (author's transl)].
Laurent B; Gonthier R; Genin C; Toulon J; Laurent P; Sabatier JC; Berthoux FC
Pathol Biol (Paris); 1982 Mar; 30(3):141-6. PubMed ID: 6808442
[TBL] [Abstract][Full Text] [Related]
12. Relationship between secretory IgA, IgA-containing (C3-fixing) circulating immune complexes, and complement components (C3, C4) in patients with obstructive jaundice.
Ohshio G; Furukawa F; Manabe T; Tobe T; Hamashima Y
Scand J Gastroenterol; 1986 Mar; 21(2):151-7. PubMed ID: 3715384
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
Gomes MA; Dambuyant C; Thivolet J; Bussy R
Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
[TBL] [Abstract][Full Text] [Related]
14. Immune complexes in retinitis pigmentosa.
Heredia CD; Huguet J; Cols N; Engel P; García-Calderón PA
Br J Ophthalmol; 1984 Nov; 68(11):811-4. PubMed ID: 6333894
[TBL] [Abstract][Full Text] [Related]
15. Circulating immune complexes in healthy persons.
Jans H; Dybkjaer E; Halberg P
Scand J Rheumatol; 1982; 11(4):194-8. PubMed ID: 7178855
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection.
Tsai JF; Margolis HS; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH
Clin Immunol Immunopathol; 1995 Apr; 75(1):39-44. PubMed ID: 7533684
[TBL] [Abstract][Full Text] [Related]
17. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
18. Immune complexes in retinitis pigmentosa.
García-Calderón PA; Engel P; Cols N; Heredia García CD
Ophthalmic Paediatr Genet; 1984 Dec; 4(3):199-202. PubMed ID: 6545398
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases.
Pastore G; Schena FP; Angarano G; Monno L; Santantonio T; Pertosa G; Schiraldi O
Ric Clin Lab; 1984; 14(1):29-35. PubMed ID: 6427879
[TBL] [Abstract][Full Text] [Related]
20. Complements as new diagnostic tools of hepatocellular carcinoma in cirrhotic patients.
Chang WY; Chuang WL
Cancer; 1988 Jul; 62(2):227-32. PubMed ID: 2454720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]